Delivery Order SPE2DB24D1104-SPE2DB24FYBD5

Award Date 8/2/24
Potential Completion Date 8/5/24
Potential Value $7.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of the ROTARIX vaccine oral syringe, 1.5 milliliters, at a ceiling value of $5,231.01. The contract is a firm fixed price, delivery order type and has a period of performance through September 6, 2024. This order is not associated with a set-aside program. AmerisourceBergen holds an...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $21,930.60 firm fixed price contract is for the supply of the ROTARIX vaccine oral syringe 1.5 ml. The contract has an ultimate completion date of March 21, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 for a comprehensive range of pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp in the amount of $8,026.38 for the supply of ROTARIX vaccines in oral syringes. The contract has a firm fixed price and an ultimate completion date of August 16, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical and a $750,000 IDC with...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for $2,153.70 and covers the delivery of the ROTARIX vaccine oral syringes (1.5 ml) through August 2024. The award is not set aside for any special designation. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with significant Indefinite Delivery Contracts (IDCs)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the ROTARIX vaccine oral syringe 1.5ML. The contract has a ceiling value of $7,237.20 and a completion date of June 12, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,654.02 firm fixed-price contract is for the delivery of the ROTARIX vaccine oral syringes (1.5 mL) and has an ultimate completion date of October 28, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,193.06 firm fixed-price contract is for the delivery of the ROTARIX vaccine oral syringe 1.5 ML. The contract has an ultimate completion date of May 2, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,537.00 firm fixed-price contract is for the supply of ROTARIX oral vaccine syringes. The contract has an ultimate completion date of May 24, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
The U.S. Defense Logistics Agency (DLA) awarded a $3,661.95 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division. The order is for the supply of 4,565,735,107 units of the ROTARIX vaccine oral syringes, 1.5 mL size. The contract has a completion date of September 10, 2024 and is not designated as a set-aside. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide the ROTARIX vaccine in oral syringes. The contract has a ceiling value of $1,514.90 and a period of performance through December 30, 2024. It is a firm-fixed price contract, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support...
  • SPE2DB24D1104
    Indefinite Delivery Contract
  • SPE2DB24D1104-SPE2DB24FYBD5
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $7,323.90 firm fixed-price contract is for the supply of ROTARIX vaccine oral syringes (1.5 ml) and has an ultimate completion date of August 5, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by the DLA and other agencies to provide a wide range of essential medical products, including specialty medications, vaccines, and medical supplies, to support military treatment facilities, veterans' hospitals, and other federal healthcare programs. This contract is not associated with a set-aside program.

Generated 11/1/24, 10:18 AM